Dermaseptin-B3

• UNSPSC Description:

  Dermaseptin-B3 inhibits the growth of Gram-positive and Gram-negative bacteria (MIC: 1.3, 2.3, 5.0, 2.6, 2.3 μM for S. aureus, P. aeruginosa, P. aeruginosa, E. (ATCC 25922), E. (54127) respectively). Dermaseptin-B3 also inhibits tumor cell proliferation[1][2].

• Target Antigen:

  Bacterial

• Type:

  Peptides

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Cancer; Infection

• Assay Protocol:

  https://www.medchemexpress.com/dermaseptin-b3.html

• Solubility:

  10 mM in DMSO

• Smiles:

  C([C@@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(O)=O)C)=O)=O)[C@H](C)C)=O)CC(C)C)=O)[C@@H](C)O)=O)CCCCN)=O)[C@@H](C)C)=O)C)=O)=O)CC(C)C)=O)C)=O)C)=O)CCC(N)=O)=O)=O)C)=O)CC(C)C)=O)CCCCN)=O)=O)[C@H](CC)C)=O)=O)CCCCN)=O)CC(C)C)=O)CCSC)=O)CC(N)=O)=O)CCCCN)=O)NC([C@@H](NC([C@H](C)N)=O)CC(C)C)=O)C=1C=2C(NC1)=CC=CC2

• Molecular Weight:

  2780.38

• References & Citations:

  [1]Charpentier S, et al. Structure, synthesis, and molecular cloning of dermaseptins B, a family of skin peptide antibiotics. J Biol Chem. 1998 Jun 12;273(24):14690-7.|[2]van Zoggel H, et al . Antitumor and angiostatic peptides from frog skin secretions. Amino Acids. 2012 Jan;42(1):385-95.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  210890-55-4